Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03396549 · ClinicalTrials.gov registry record · NA
Effect of tDCS Montage on Measures of Appetite
A NA study of Eating Behavior, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT03396549: Completed NA study of Eating Behavior, sponsored by University of Alabama at Birmingham.
NCT03396549 is a NA study of Eating Behavior that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 28 participants, below the 175-participant average among 20 other Eating Behavior trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03396549, a NA study of Eating Behavior, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim is to validate a new sham (control) method for use in transcranial direct current stimulation (tDCS) that is less discernible to participants from the real condition. Participants are often able to tell real from sham conditions. Correctly guessing real from sham undermines the integrity of evaluations of the value of tDCS as a treatment tool as responses may be in part or entirely the result of treatment expectation effects. The study will test a new sham method to reduce food craving and eating and test how much participants are able to discern it from the real or 'target' condition.
Primary Outcome
Amount of food eaten in kcals and food craving in ratings for degree of wanting a particular food displayed on computer screen.
Conditions Studied
Interventions
- DEVICE new sham tDCS
- DEVICE real tDCS
Study Locations (1)
Alabama
- University of Alabama at Birmingham (UAB) - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2018-03-14 |
| Phase | NA |
What the finished NCT03396549 record still lists
NCT03396549 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 175-participant average among 20 other Eating Behavior trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Eating Behavior appearing as the primary indexed condition, and to 2 interventions - of which new sham tDCS is the first listed.
NCT03396549 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03396549 about?
NCT03396549 is a clinical study titled "Effect of tDCS Montage on Measures of Appetite". The aim is to validate a new sham (control) method for use in transcranial direct current stimulation (tDCS) that is less discernible to participants from the real condition. Participants are often able to tell real from sham conditions. Correctly guessing real from sham undermines the integrity of ...
What is the current status of trial NCT03396549?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-03-07. Estimated completion is 2018-03-14.
What conditions does trial NCT03396549 study?
This clinical trial studies the following conditions: Eating Behavior.
What interventions are being tested in trial NCT03396549?
The interventions under investigation include: new sham tDCS (DEVICE), real tDCS (DEVICE).
Who is sponsoring clinical trial NCT03396549?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03396549 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03396549's enrollment target sits among peer trials
28 18th of 20 higher than 3 of 20 other Eating Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eating Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mother-Baby Study - Caloric Compensation Index (COMPX)
RECRUITING · NA
-
Food for Thought: Executive Functioning Around Eating Among Children
RECRUITING · NA
-
Mother-Baby Study - Relative Reinforcing Value (RRV)
RECRUITING · NA
-
Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women
RECRUITING · NA
-
Mother-Baby Study - Eating in the Absence of Hunger (EAH)
RECRUITING · NA
-
Nurturing Needs Study: Parenting Food Motivated Children
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI